Skip to main content
Independent Medical Education, brought to you by Springer Healthcare IME

Continuing Medical Education

Our full array of independent CME content is developed by Springer Healthcare IME in collaboration with a dedicated global network of scientific experts. All of these programs combine high-value scientific content with the latest innovations in educational design to inspire you to maximize your learning and make measurable change in your clinical practice.

News | Articles | Videos (Link opens in a new window)

Expert insights, latest news and cutting-edge data reported from The Liver Meeting, Boston covering PBC treatment to arm HCPs with the latest information to optimize patients’ outcomes.

Supported by:
  • Ipsen

eLearning | Interviews (Link opens in a new window)

This independent educational program aims to highlight advances in the diagnosis, treatment, and management of patients with hemophilia that have the potential to improve patients’ outcomes and quality of life.

Supported by:
  • Sanofi

Webcast | eLearning | Infographic (Link opens in a new window)

Expert insights into new data on novel PET biomarkers and tracers, with practical learning to detect early signs of Alzheimer's disease, advance diagnostic accuracy, and identify those who would benefit from disease-modifying therapies.

Supported by:
  • Lilly

eLearning | Infographic (Link opens in a new window)

Animated, interactive expert-led website focusing on  neuroinflammation and its role in the development of Alzheimer’s disease.

This program is not available to users in the UK and US.

Supported by:
  • Novo Nordisk A/S

Digital Treatment Map (Link opens in a new window)

Practical, expert-led digital map designed to guide treatment of type 2 diabetes with GLP‑1RAs.

This program is not available to users in the UK and US.

Supported by:
  • Novo Nordisk A/S

Webcast | Videos | Cases (Link opens in a new window)

Identifying molecular biomarkers is crucial in determining the best targeted treatment options for your patients with advanced thyroid cancer.

Join our expert-led multi-format educational program that explores the continuing discovery of new genomic targets and delivers the latest research in molecular testing and the application of targeted therapies for thyroid cancer.

Start by watching our webcast and short vodcasts.

Supported by:
  • Lilly

eLearning | Interviews | Digital Treatment Map (Link opens in a new window)

Expert-led, multiformat program which will address the individualized management of NSCLC, through education on the detection of NTRK gene fusions, current evidence-based guidelines, and new and emerging therapies. Will also include guidance on integrating shared decision making into your clinical practice, drawing on insights from a patient on how best to communicate.

CME: 1.0 AMA PRA Category 1 Credit(s)™

Supported by:
  • Bayer HealthCare Pharmaceuticals Inc.

eLearning | Interviews | Cases (Link opens in a new window)

Knowledge center focusing on improving the individualized management of HR+/HER2- early breast cancer.

CME: 0.75 AMA PRA Category 1 Credit(s)™

Supported by:
  • Lilly

Webcast | Patient Cases (Link opens in a new window)

Multiformat program improving awareness, diagnosis and management of patients with adult growth hormone deficiency.

CME: 1.5 AMA PRA Category 1 Credit(s)™

Supported by:
  • Novo Nordisk Health Care AG

Webcast | Videos (Link opens in a new window)

Discussion-based webcast addressing the causes of clinical inertia in type 2 diabetes.

CME: 1.0 AMA PRA Category 1 Credit(s)™

Supported by:
  • Lilly

Digital Treatment Map (Link opens in a new window)

Practical, expert-led digital map designed to guide treatment of ALK- and ROS1-mutation positive NSCLC.

Supported by:
  • Pfizer

eLearning | Podcasts | Cases (Link opens in a new window)

Multi-format program raising awareness of the rare disease fibrodysplasia ossificans progressiva (FOP).

Supported by:
  • Ipsen

eLearning | Interviews | Cases (Link opens in a new window)

Multiformat program highlighting evidence-based best practice for the management of metastatic urothelial carcinoma.

Supported by:
  • Pfizer and Merck Healthcare KGaA, Darmstadt, Germany

News | Articles | Podcasts | Cases (Link opens in a new window)

Join Prof. Martin Savage and expert colleagues for this series of interviews exploring how to successfully implement precision medicine into the management of pediatric endocrine disorders.

Supported by:
  • Merck Healthcare KGaA, Darmstadt, Germany